arrow
R

Rami Rhaiem

centre hospitalo-universitaire de reims
H指数:15
被引数:840

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pre and postoperative machine learning models and point-based scores to predict risk of early recurrence in upfront resected large Hepatocellular carcinoma

术前和术后机器学习模型及基于点的评分系统,用于预测初始切除的大肝癌早期复发的风险

2025-11-280
PRE
Hepatic Metastases Management: A Comparative Review of Surgical Resection, Thermal Ablation, and Stereotactic Body Radiation Therapy.

肝转移管理:外科切除、热消融和立体定向体部放射治疗的比较综述。

2025-08-050
PRE
Do Trisectionectomies Improve Outcomes for Localized Bismuth-Corlette Type II and III Perihilar Cholangiocarcinoma? Insights From a Nationwide French Cohort Study

三切术是否能改善局限性Bismuth-Corlette II型和III型肝门部胆管癌的预后?——来自一项法国全国队列研究的见解

2025-08-010
PRE
ASO Visual Abstract: Patterns of Site and Timing of Recurrence after Curative Resection in Single and Multiple Large Hepatocellular Carcinoma: A Multicenter International Comprehensive Analysis

ASO视觉摘要:单发和多发大型肝细胞癌根治性切除术后复发部位与时间模式:一项多中心国际综合分析

2025-07-240
PRE
ASO Author Reflections: Complete Pathological Response after Neoadjuvant Treatment for Pancreatic Ductal Adenocarcinomas-Curative Surgery in Cured Patients?
2025-02-010
PRE
ASO Visual Abstract: Prognosis Associated with Complete Pathological Response Following Neoadjuvant Treatment for Pancreatic AdenOcarciNOma in the FOFLIRINOX Era: The Multicenter TONO Study
2025-01-290
PRE
Prognosis Associated with Complete Pathological Response Following Neoadjuvant Treatment for PancreaTic AdenOcarciNOma in the FOFLIRINOX Era: the Multicenter TONO Study

Fofirinox时代胰腺腺癌新辅助治疗后完全病理缓解的预后: 多中心TONO研究

2025-01-081
PRE
Selective internal radiation therapy across Barcelona Clinic Liver Cancer (BCLC) stages of hepatocellular carcinoma: literature review

巴塞罗那临床肝癌 (BCLC) 肝细胞癌的选择性内部放射治疗: 文献综述

2024-12-011
OAAI
Critical appraisal of surgical margins according to KRAS status in liver resection for colorectal liver metastases: Should surgical strategy be influenced by tumor biology?
SURGERY
IF2.7
2024-07-017
PRE
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma
2023-12-1414
OAAI
ERS: A simple scoring system to predict early recurrence after surgical resection for hepatocellular carcinoma
2023-08-1413
OAAI
Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma

巢蛋白作为肝细胞-胆管癌的诊断和预后标志物

2022-12-0119
OAAI